Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Cell Therapy
  6.  » Quality & Regulatory Support from pre-IND to Commercialization

Quality & Regulatory Support from pre-IND to Commercialization

Summary: Catalent has made significant investments in the cell and gene therapy space with strategic acquisitions and commitment to grow and innovate. A quality and regulatory powerhouse has emerged by combining leaders in the biologics and advanced therapeutics industry.

 

Click here to download the Fact Sheet